False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer

被引:3
|
作者
Barbaro, Daniele [1 ]
Campenni, Alfredo [2 ]
Forleo, Raffaella [1 ]
Lapi, Paola [1 ]
机构
[1] UO Endocrinol ASL North West, Tuscany, Italy
[2] Univ Messina, Dept Biomed & Dent Sci & Morpho Funct Imaging, Nucl Med Unit, I-98121 Messina, Italy
关键词
Differentiated thyroid cancer; False-positive radioiodine; False-positive; 131-I; SPECT-CT; Sodium iodine symporter; I-131; SCINTIGRAPHY; SPECT/CT; PATIENT;
D O I
10.1007/s12020-023-03338-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and purposeFalse-positive radioiodine uptake can sometimes be observed with post-radioiodine treatment (RIT) whole body scanning. Radioiodine pitfall has often been reported as being caused by benign or inflammatory disease, or, in some cases, by tumor lesions. This paper reviews the possible causes of such false-positive imaging, and suggests possible reasons for suspecting these pitfalls.Methods and resultsOnline databases, including MEDLINE (via PubMed), Embase, ISI Web of Science, Google Scholar, and Scopus, were systematically examined, using different keyword combinations: "radioiodine false-positive imaging", "131 I false-positive imaging" and " RAI false-positive imaging". An illustrative case was described. Excluding cases in which SPECT/CT was not performed, a total of 18 papers was found: 17 case reports and one series regarding false-positive iodine-131 uptake after RIT.ConclusionsThe prevalence of radioiodine pitfall was significantly reduced through the use of SPECT/CT imaging, though its possible presence has always to be taken into account. Inflammation, passive iodine accumulation, other tumors, and, sometimes, unknown causes can all potentially generate false-positive imaging. Missing detection of false-positive imaging could result in over-staging and inappropriate RIT or it could lead to the non-detection of other cancers. We examine the reasons for these possible pitfalls.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 50 条
  • [1] False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
    Daniele Barbaro
    Alfredo Campennì
    Raffaella Forleo
    Paola Lapi
    [J]. Endocrine, 2023, 81 : 30 - 35
  • [2] False-Positive Uptake of Radioiodine in Renal Hamartoma in a Patient With Differentiated Thyroid Cancer
    Shen, Guohua
    Qi, Zhongzhi
    Huang, Rui
    Liu, Bin
    Kuang, Anren
    [J]. CLINICAL NUCLEAR MEDICINE, 2017, 42 (09) : 709 - +
  • [3] False-Positive Radioiodine Uptake in the Cervix in a Patient with Thyroid Cancer
    Singh, Parneet
    Parida, Girish Kumar
    Singhal, Tejasvini
    Kumar, Pramit
    Emerson, Ralph
    Agrawal, Kanhaiyalal
    [J]. INDIAN JOURNAL OF NUCLEAR MEDICINE, 2023, 38 (03): : 270 - 272
  • [4] CEREBRAL FALSE-POSITIVE RADIOIODINE UPTAKE
    Piciu, D.
    Piciu, A.
    Irimie, A.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2012, 8 (03) : 495 - 495
  • [5] Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer
    Chudgar, Amy V.
    Shah, Jagruti C.
    [J]. RADIOGRAPHICS, 2017, 37 (01) : 298 - 315
  • [6] FALSE-POSITIVE RADIOIODINE UPTAKE IN LUNG-CARCINOMA
    LANGSTEGER, W
    KOLTRINGER, P
    WOLF, G
    EBER, B
    SEMLITSCH, G
    EBER, O
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (12) : 2056 - 2057
  • [7] False-positive radioiodine uptake in the abdomen and the pelvis: Radioiodine retention in the kidneys and review of the literature
    Bakheet, SMB
    Hammami, MM
    Powe, J
    [J]. CLINICAL NUCLEAR MEDICINE, 1996, 21 (12) : 932 - 937
  • [8] Radioiodine treatment for differentiated thyroid cancer
    Vini, L
    Harmer, C
    [J]. CLINICAL ONCOLOGY, 2000, 12 (06) : 365 - 372
  • [9] FALSE-POSITIVE RADIOIODINE UPTAKE IN LUNG-CARCINOMA - REPLY
    MISAKI, T
    TAKEUCHI, R
    MIYAMOTO, S
    KASAGI, K
    MATSUI, Y
    KONISHI, J
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (12) : 2057 - 2057
  • [10] An Unusual False-Positive Uptake of Radioiodine Caused by Breast Implants
    Wang, Yu
    Jiang, Lisha
    Xu, Yangmengyuan
    Zhang, Xinyue
    Liu, Bin
    [J]. CLINICAL NUCLEAR MEDICINE, 2022, 47 (07) : 646 - 647